Sitemap
- Level: 0
Home
- Level: 1
Products
- Level: 2 Additives
- Level: 2 Adhesives and Sealants
- Level: 2 Coatings & dispersions
- Level: 2 Conductive materials
- Level: 2
Elastomers
- Level: 3 High consistency rubbers
- Level: 3 Liquid silicone rubbers
- Level: 3 Low viscosity elastomers
- Level: 2 Inks
- Level: 2 Lubricants
- Level: 2 Polymers & catalysts
- Level: 2 Potting & encapsulating materials
- Level: 2 Primers
- Level: 2 Skin care ingredients
- Level: 1
Applications
- Level: 2
Healthcare
- Level: 3 Drug delivery
- Level: 3 Medical implants
- Level: 3 General healthcare
- Level: 3 Beauty care
- Level: 3 Diagnostics
- Level: 3 Nutraceuticals
- Level: 2
Advanced technologies & applied materials
- Level: 3 Aviation and defense
- Level: 3 Space
- Level: 3 Semiconductor and MEMS
- Level: 3 Optoelectronics and electronics
- Level: 2
Healthcare
- Level: 1 Terms of use
- Level: 1 Privacy policy
- Level: 1 NuSil terms & conditios of sale
- Level: 1 NuSil terms & conditions of purchase
- Level: 1 Silicone definitions
- Level: 1 Resource library
- Level: 1
Products
- Level: 0
Home
- Level: 1
About
- Level: 2 Mission, vision, values
- Level: 2 Leadership
- Level: 2 History
- Level: 2 Global footprint
- Level: 2
Sustainability
- Level: 3
People & Culture
- Level: 4 Attracting & Developing Our Associates
- Level: 4 Caring for Our Associates
- Level: 3
Innovation & Environment
- Level: 4 Operational Sustainability
- Level: 4 Sustainable Product Innovation
- Level: 4 Environmentally Preferred Products
- Level: 3
Community Engagement
- Level: 4
Avantor Foundation
- Level: 5
About us
- Level: 6 Letter from the president
- Level: 6 Avantor Foundation history
- Level: 6 Avantor Foundation Board
- Level: 5
Explore our grantmaking
- Level: 6 Grantee highlights
- Level: 6 Grant distribution
- Level: 5
Programs
- Level: 6 Avantor matching program
- Level: 5
About us
- Level: 4 Associate Volunteerism
- Level: 4
Avantor Foundation
- Level: 3
Governance & Integrity
- Level: 4 Compliance & certification
- Level: 4 Responsible Supplier Program
- Level: 4 Supplier diversity
- Level: 4 Avantor Business System
- Level: 4
Policies & Statements
- Level: 5 Code of Ethics and Conduct
- Level: 5 Political Contributions Disclosure
- Level: 3 Sustainability Reports
- Level: 3
People & Culture
- Level: 2 Our DEI Commitment
- Level: 2
Thought leadership
- Level: 3
Biopharma
- Level: 4 Artificial intelligence driving inventory management for improved single-use systems manufacturing
- Level: 4 Advancing mRNA vaccine production management
- Level: 4 Industry perspective: Scale up challenges for cell & gene therapy manufacturers
- Level: 4 Four best practices for single-use supply chain success
- Level: 4 CPhI Roundtable Discussion
- Level: 4 Solving cost and supply challenges in biopharma downstream processing
- Level: 4 Optimizing single-use manufacturing through associate training
- Level: 4 Processing challenges in realizing the future potential of mRNA vaccines and therapeutics
- Level: 4 Viral Vectors: collaboration is key to fixing stability and other challenges
- Level: 4 Approaches to alleviating subcutaneous pain at injection sites, a study
- Level: 4 Industry perspective: much needed advances in biopharma chromatography
- Level: 4 Raw data – a 4.0 approach to materials offers process development benefits
- Level: 4 Tim Korwan, Director, New Product Introduction in Avantor’s single-use business spoke to BioSpectrum International in April 2021 about the integration of single-use technologies into fluid handling systems
- Level: 4 Narayana Rao, Vice President, Biopharma, AMEA, spoke to BioSpectrum in May, 2021, about the ways Avantor contributes to the biopharma space
- Level: 4 Interview with Narayana Rao, Vice President, Biopharma, AMEA in BioSpectrum Asia Edition (April 2021) on COVID-19 vaccine needs
- Level: 4 Applying lessons from the semiconductor industry to biopharmaceutical production
- Level: 4 Formulation Development for AAV Viral Vectors
- Level: 4 Raw Material Supply Chain Security for Cell and Gene Therapies
- Level: 4 Novel Resins for Downstream Process Intensification
- Level: 4 Removing bottlenecks in downstream processing purification
- Level: 4 Bioprocessing in a Post COVID-19 World
- Level: 4 Charting the rise of single-use
- Level: 4 Alternative buffer management strategies to achieve downstream process improvements
- Level: 4 Vaccine manufacturing: COVID-19 and beyond
- Level: 4 Single-use technology in cell and gene therapies
- Level: 4 Improving mAb Manufacturing Productivity
- Level: 4 Advancing gene therapy by solving challenges in scale-up & manufacturing
- Level: 4 Addressing Key Challenges Optimizing Downstream Bioprocessing
- Level: 4 Managing Single Use Supply Chain
- Level: 4 Optimizing Upstream Bioprocessing
- Level: 4 Considerations in Controlling Glycosylation
- Level: 4 Challenges in Chromatography
- Level: 4 Opportunities and challenges in cell and gene therapy development
- Level: 3 Healthcare
- Level: 3 Advanced technologies & applied materials
- Level: 3
Services
- Level: 4 Decentralized Clinical Trials
- Level: 4 Science of lab management
- Level: 4 The rise of home diagnostics in clinical trials
- Level: 4 10 fundamentals of sample security
- Level: 4 Logistics journey of a sample
- Level: 4 Focus on quality
- Level: 4 Partnering to support the lab of the future
- Level: 4 Building the lab of the future, today
- Level: 4 The potential of wearable technology for the future of clinical trial research
- Level: 4 Meeting today’s changing needs: the vital role of biorepositories and archiving facilities in advancing clinical research
- Level: 4 The rapid growth of clinical trials for COVID-19
- Level: 4 The importance of logistics and shipping for remote testing and diagnostics
- Level: 4 How to avoid costly clinical research delays
- Level: 4 Using social media for clinical trial recruitment
- Level: 4 Why Clinical Trial Equipment Rental Could Transform Your Trial
- Level: 4 Maximize your clinical trials budget
- Level: 4 Success story: Small molecule purification
- Level: 3 Innovation and Quality
- Level: 3
COVID-19 Success stories
- Level: 4 Coronavirus detection
- Level: 4 Streamlining allocation of critical supplies
- Level: 4 Direct-to-patient custom kitting solutions
- Level: 4 Multi-site inventory management
- Level: 4 Centralized inventory management
- Level: 3
Biopharma
- Level: 2
Careers
- Level: 3 Frequently Asked Questions
- Level: 2
Brands
- Level: 3 NuSil®
- Level: 3 J.T.Baker®
- Level: 3 VWR®, part of Avantor
- Level: 3 Macron Fine Chemicals™
- Level: 3 Puritan Products™
- Level: 3 BeneSphera™
- Level: 3 RANKEM™
- Level: 3 POCH™
- Level: 1
Industries
- Level: 2
Biopharma
- Level: 3 Monoclonal antibodies (mAbs)
- Level: 3 Recombinant proteins
- Level: 3 Vaccines
- Level: 3 Cell therapies
- Level: 3 Gene therapies
- Level: 3 mRNA vaccines & therapies
- Level: 3
Fluid-handling
- Level: 4 Quality and risk mitigation
- Level: 4 Comprehensive and customized solutions
- Level: 4 Global footprint
- Level: 3 Buffer management
- Level: 3 Small molecule products
- Level: 3 The Process of Drug Development
- Level: 2
Healthcare
- Level: 3 Drug delivery
- Level: 3 Medical implants
- Level: 3 General healthcare
- Level: 3 Beauty care
- Level: 3 Diagnostics
- Level: 3 Nutraceuticals
- Level: 2
Education
- Level: 3 Academic research
- Level: 3 Laboratory research
- Level: 3 Quality control
- Level: 3 Environmental testing
- Level: 2
Advanced technologies & applied materials
- Level: 3 Aviation and defense
- Level: 3 Space
- Level: 3 Semiconductor and MEMS
- Level: 3 Optoelectronics and electronics
- Level: 3 Food and beverage
- Level: 2
Biopharma
- Level: 1
Avantor Services
- Level: 2
Lab & production services
- Level: 3
Procurement and material management services
- Level: 4 Procurement and supply chain services
- Level: 4 Inventory management solutions
- Level: 4 Chemical management solutions
- Level: 3 General lab services
- Level: 3
Technical lab services
- Level: 4 Scientific services
- Level: 4 Media and buffer preparation
- Level: 4 Sample management services
- Level: 3
Production services
- Level: 4 Critical environment & sanitization
- Level: 4 Production process readiness
- Level: 4 Planning & material management
- Level: 3
Business process consulting
- Level: 4 Lean consulting
- Level: 4 Project management
- Level: 3
Procurement and material management services
- Level: 2
Clinical services
- Level: 3
Custom kitting solutions
- Level: 4 Logistics and freight management
- Level: 4 Kitting solutions
- Level: 4 Services
- Level: 3
Clinical trial equipment & ancillary solutions
- Level: 4 Sourcing
- Level: 4 Supply
- Level: 4 Service
- Level: 4 End of study
- Level: 4 Drug and comparator sourcing
- Level: 3
Biorepository & archiving services
- Level: 4 Storage & facilities
- Level: 4 Services
- Level: 4 Aliquoting
- Level: 3 The Future of Clinical Trials
- Level: 3
Custom kitting solutions
- Level: 2
Procurement & sourcing services
- Level: 3 MarketSource sourcing solutions
- Level: 3 MarketSource online product portfolio
- Level: 2
Lab equipment services
- Level: 3 Multi-vendor technical services
- Level: 3 Compliance services
- Level: 3 Equipment management services
- Level: 2
Commercial kitting & services
- Level: 3 Kitting services
- Level: 3 Logistics and freight management
- Level: 3 General healthcare products
- Level: 3 Package testing and development
- Level: 2
Digital solutions
- Level: 3
Software solutions
- Level: 4 Inventory Manager
- Level: 4 Chemical Manager
- Level: 4 Equipment Manager
- Level: 3 Hardware solutions
- Level: 3 Data, metrics and analytic solutions
- Level: 3
Software solutions
- Level: 2 Downstream optimization services
- Level: 2 The journey of a drug
- Level: 2
Lab & production services
- Level: 1
Our offerings
- Level: 2
Materials and consumables
- Level: 3
High-purity silicones
- Level: 4 Additives
- Level: 4 Adhesives and Sealants
- Level: 4 Conductive materials
- Level: 4 Coatings & dispersions
- Level: 4
Elastomers
- Level: 5 High consistency rubbers
- Level: 5 Liquid silicone rubbers
- Level: 5 Low viscosity elastomers
- Level: 4 Inks
- Level: 4 Lubricants
- Level: 4 Polymers & catalysts
- Level: 4 Potting & encapsulating materials
- Level: 4 Primers
- Level: 4 Skin care ingredients
- Level: 3
High-purity silicones
- Level: 2 Equipment and instrumentation
- Level: 2
Digital Offerings by SmartScience
- Level: 3 Workflow optimization
- Level: 3 Digital commerce
- Level: 3
Data informatics
- Level: 4 Smart Buttons
- Level: 3 Digital services
- Level: 2
Solutions supporting COVID-19
- Level: 3 Virus detection
- Level: 3 Therapy development
- Level: 3 Clinical trials
- Level: 3 Vaccine and therapy production
- Level: 2
Materials and consumables
- Level: 1
Resources
- Level: 2 Ask Avantor
- Level: 2 Contact
- Level: 2 Resource library
- Level: 2
Webinars
- Level: 3
Biopharma
- Level: 4 Adopting novel technologies to improve monoclonal antibody processes
- Level: 4 Novel approach to purification and viral inactivation of new class of mAbs
- Level: 4 Risk mitigation and process debottlenecking in continuous biomanufacturing
- Level: 4 Increased Viral Clearance in Downstream Process Manufacturing Through Use of Novel Purification Resins and Additives
- Level: 4 Efficient raw material management for improving bioprocess throughput and flexibility
- Level: 4 Use of a Novel Cell Lysis Buffer for Protection of AAVs and Enhancing Manufacturing Efficiency
- Level: 4 A Changing Landscape for Biopharma
- Level: 4 Accelerating the commercial manufacturing of novel vaccines and other therapeutics
- Level: 4 Faster, better, together: Biopharma collaboration trends in the pandemic, and the future of medicine
- Level: 4 Understanding monoclonal antibody aggregate behavior impacting chromatographic process efficiency
- Level: 4 Improved antibody purification process through use of additives
- Level: 4 Novel Purification Technologies and Approaches to Maximize Speed, Efficiency and Process Optimization
- Level: 4 Key challenges and potential solutions for eliminating bottlenecks and optimizing biopharma downstream processes
- Level: 4 Solutions to manage complexity in global single-use supply chain for vaccines manufacturing
- Level: 4 Process debottlenecking in buffer and media prep using enhanced raw material release/delivery strategies
- Level: 4 Downstream Process Intensification with Novel Chromatography Resins for Enhanced Monoclonal Antibody Purification
- Level: 4 Digitalizing biopharma
- Level: 4 Understanding the critical roles of cGMP chemicals and single-use technologies in cell & gene therapy manufacturing
- Level: 4 Novel Single-use Solutions for Cell & Gene Therapy Manufacturing
- Level: 4 Innovative direct dispense technology to ensure in-time delivery and release during continuous biomanufacturing
- Level: 4 Designing Novel Fluid Sampling Systems for GMP Operations
- Level: 3
Healthcare
- Level: 4 Designing with Silicones
- Level: 3
Advanced technologies & applied materials
- Level: 4 Designing with Silicone for Space
- Level: 3 Chemicals
- Level: 3
Chromatography
- Level: 4 Troubleshooting Methods in Gas Chromatography
- Level: 4 Adapting well known chromatographic techniques for the analysis of biomolecules
- Level: 4 Driving Results With Effective U/HPLC Troubleshooting
- Level: 4 Oligonucleotide analysis
- Level: 4 Streamlined reversed-phase method development using combined column screening and software modelling approach
- Level: 4 A UHPLC/HPLC Method Development Strategy with Complementary Stationary Phases to Maximise Selectivity and Resolution
- Level: 4 Data Integrity for Pharmaceutical Chromatographers
- Level: 4 Method development strategies in HILIC conditions
- Level: 4 Practical UHPLC
- Level: 3
Controlled environment
- Level: 4 EU GMP Draft Annex 1
- Level: 4 Introduction to the EU Biocidal Products Regulation
- Level: 3 LIfe science
- Level: 3
Biopharma
- Level: 2 Avantor® ISO Certifications
- Level: 2 Grade definitions
- Level: 2 Silicone definitions
- Level: 2 Journey of Life Sciences
- Level: 2 Videos
- Level: 1
Working with Avantor
- Level: 2 How to buy
- Level: 2 How to ship
- Level: 2 How to sell
- Level: 2 Innovation at Avantor
- Level: 2 Quality and compliance
- Level: 2 Management of change
- Level: 1 Find a channel partner
- Level: 1 Certificate of Analysis country codes
- Level: 1
Moves science forward
- Level: 2 Biopharma
- Level: 2 Healthcare
- Level: 2 Research
- Level: 2 Lab services
- Level: 2 Clinical trials
- Level: 1
COVID-19
- Level: 2 Vigilance
- Level: 2 Business continuity
- Level: 2 Service levels
- Level: 1 Terms of use
- Level: 1 Privacy policy
- Level: 1 EEO and Affirmative Action Statement
- Level: 1 Careers - Privacy policy
- Level: 1 Terms and conditions of sale
- Level: 1 Avantor Performance Materials Poland S.A. terms & conditions of sale
- Level: 1 NuSil terms & conditions of sale
- Level: 1 NuSil terms & conditions of purchase
- Level: 1 Avantor Product Management help messaging
- Level: 1
About